Enlarge / A box of Paxlovid, the Pfizer antiviral drug. reader comments 39 with 23 posters participating Share this story Pfizer’s antiviral pill Paxlovid is among the most treasured tools for hammering COVID-19; it can knock back the relative risk of hospitalization and death by 89 percent in unvaccinated patients at high risk of severe ..
Enlarge / Pfizer headquarters in Manhattan on November 19, 2020. reader comments 167 with 88 posters participating Share this story Covid-19 Coverage View more stories An antiviral pill developed by Pfizer reduced COVID-19 hospitalizations and deaths by about 89 percent in a trial involving 774 newly infected people at risk of developing severe disease. That’s ..
Enlarge / A Merck sign stands in front of the company’s building on October 2, 2013, in Summit, New Jersey. reader comments 266 with 155 posters participating Share this story Covid-19 Coverage View more stories An oral antiviral drug appears to cut the risk of hospitalization and death from COVID-19 by roughly 50 percent in ..